Corbus Pharmaceuticals Holdings (CRBP) Net Income towards Common Stockholders (QoQ) (2013 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Net Income towards Common Stockholders (QoQ) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 135.08 Mn | 107.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 105.87% |
| Jun 30, 2025 | 3.15% |
| Mar 31, 2025 | -1,210.96% |
| Dec 31, 2024 | 16.95% |
| Sep 30, 2024 | 60.55% |
| Jun 30, 2024 | 401.59% |
| Mar 31, 2024 | 101.71% |
| Dec 31, 2023 | -5.41% |
| Sep 30, 2023 | -13.92% |
| Jun 30, 2023 | 46.88% |
| Mar 31, 2023 | -60.20% |
| Dec 31, 2022 | -31.97% |
| Sep 30, 2022 | 33.70% |
| Jun 30, 2022 | -44.88% |
| Mar 31, 2022 | 14.81% |
| Dec 31, 2021 | 27.94% |
| Sep 30, 2021 | 16.92% |
| Jun 30, 2021 | -8.35% |
| Mar 31, 2021 | 25.94% |
| Dec 31, 2020 | 38.74% |